What is the ticker symbol for Elicio Therapeutics?

Elicio Therapeutics trades under the ticker ELTX on NASDAQ.

What sector does Elicio Therapeutics operate in?

Elicio Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ELTX in a portfolio?

PortView shows ELTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Elicio Therapeutics (ELTX) Stock Analysis

NASDAQHealthcareBiotechnology

$2.52-1.76%

1-year price historyRange $2.52 – $14.85

52-week range$2.52

$2.48$16.00

What Elicio Therapeutics does

Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.

Key metrics

Market cap

$47.95M

P/E (TTM)

-1.16

EPS (TTM)

$-2.17

Beta

1.88

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$3.22

200-day avg

$8.12

52-week high

$16.00

52-week low

$2.48

CEO

Robert T. Connelly

ETFs linked to ELTX

Broad-market and Healthcare sector ETFs an investor holding Elicio Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ELTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ELTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Elicio Therapeutics?: Elicio Therapeutics trades under the ticker ELTX on NASDAQ.
Which exchange is ELTX listed on?: ELTX is listed on NASDAQ.
What sector does Elicio Therapeutics operate in?: Elicio Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ELTX in a portfolio?: PortView shows ELTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.